Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free CXDO Stock Alerts

Crexendo (CXDO) Financials

Crexendo logo
$7.66 -0.18 (-2.30%)
Closing price 04:00 PM Eastern
Extended Trading
$7.54 -0.12 (-1.50%)
As of 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Crexendo

Annual Income Statements for Crexendo

This table shows Crexendo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -4.54 -2.79 -0.93 -0.22 1.14 -2.24 -2.45 -35 -0.36 1.68 5.07
Consolidated Net Income / (Loss)		 -4.54 -2.79 -0.93 -0.22 1.14 7.94 -2.45 -35 -0.36 1.68 5.07
Net Income / (Loss) Continuing Operations		 -4.54 -2.79 -0.93 -0.22 1.14 -2.24 -2.45 -35 -0.36 1.68 5.07
Total Pre-Tax Income 		-4.55 -2.78 -0.92 -0.21 1.15 1.90 -2.91 -36 -0.26 1.89 5.37
Total Operating Income		 -4.84 -2.76 -0.73 -0.21 1.14 0.99 -2.81 -37 -1.69 1.82 4.69
Total Gross Profit		 4.25 5.49 6.92 8.09 10 28 27 36 50 45 65
Total Revenue		 7.82 9.12 10 12 14 33 28 38 53 61 68
Operating Revenue		 7.82 9.12 10 12 14 33 28 38 53 61 68
Total Cost of Revenue		 3.58 3.63 3.27 3.82 4.35 4.95 1.53 1.64 3.33 16 2.84
Operating Cost of Revenue		 3.58 3.63 3.27 3.82 4.35 4.95 1.53 1.64 3.33 16 2.84
Total Operating Expenses		 9.09 8.26 7.66 8.30 8.95 26 29 73 52 43 61
Selling, General & Admin Expense		 5.86 4.90 4.07 4.09 4.24 5.11 11 13 14 14 15
Marketing Expense		 2.44 2.53 2.83 3.40 3.86 4.15 8.26 12 15 17 18
Research & Development Expense		 0.78 0.83 0.75 0.80 0.85 1.19 1.40 3.96 4.86 5.55 5.72
Other Operating Expenses / (Income)		 - - - - - 15 9.14 12 18 6.79 22
Total Other Income / (Expense), net		 0.29 -0.02 -0.19 -0.00 0.01 1.82 -0.10 1.22 1.43 0.07 0.68
Interest Expense		 0.03 0.14 0.21 0.01 0.01 -0.93 0.08 0.08 0.12 0.04 0.02
Interest & Investment Income		 0.02 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.19 0.64
Other Income / (Expense), net		 0.29 0.11 0.01 0.00 0.02 0.88 -0.02 1.30 1.54 -0.08 0.06
Income Tax Expense		 -0.01 0.01 0.01 0.02 0.01 6.04 -0.47 -0.76 0.10 0.21 0.30
Basic Earnings per Share		 ($0.35) ($0.21) ($0.07) ($0.02) $0.08 $0.50 ($0.12) ($1.54) ($0.01) $0.06 $0.17
Weighted Average Basic Shares Outstanding		 12.96M 13.36M 13.94M 14.33M 14.57M 15.77M 20.28M 22.94M 25.94M 26.76M 29.68M
Diluted Earnings per Share		 ($0.35) ($0.21) ($0.07) ($0.02) $0.07 $0.46 ($0.12) ($1.54) ($0.01) $0.06 $0.16
Weighted Average Diluted Shares Outstanding		 12.96M 13.36M 13.94M 14.33M 15.56M 17.42M 20.28M 22.94M 25.94M 30.02M 31.64M
Weighted Average Basic & Diluted Shares Outstanding		 13.25M 13.65M 14.29M 14.39M 14.90M 17.42M 20.28M 25.70M 26.28M 27.90M 31.15M

Quarterly Income Statements for Crexendo

This table shows Crexendo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 1.70 0.01 0.43 0.59 0.15 0.45 1.17 1.23 1.45 1.22 0.58
Consolidated Net Income / (Loss)		 1.70 0.06 0.43 0.59 0.15 0.51 1.17 1.23 1.45 1.22 0.58
Net Income / (Loss) Continuing Operations		 1.70 0.01 0.43 0.59 0.15 0.45 1.17 1.23 1.45 1.22 0.58
Total Pre-Tax Income 		1.74 0.08 0.46 0.62 0.19 0.62 1.22 1.28 1.49 1.38 0.61
Total Operating Income		 0.36 0.04 0.48 0.58 0.14 0.63 1.15 1.10 1.31 1.13 0.44
Total Gross Profit		 9.78 17 14 14 15 19 12 16 17 17 19
Total Revenue		 14 14 14 15 16 16 16 17 17 18 21
Operating Revenue		 14 14 14 15 16 16 16 17 17 18 21
Total Cost of Revenue		 4.10 -2.49 0.73 0.70 1.08 -2.63 4.09 0.69 0.89 0.66 1.67
Operating Cost of Revenue		 4.10 -2.49 0.73 0.70 1.08 -2.63 4.09 0.69 0.89 0.66 1.67
Total Operating Expenses		 9.41 17 13 13 14 18 11 15 15 16 19
Selling, General & Admin Expense		 3.31 3.32 3.30 3.43 3.70 3.41 3.52 3.59 3.78 3.84 5.06
Marketing Expense		 3.50 3.75 4.03 3.96 4.22 4.33 4.29 4.37 4.52 4.59 5.65
Research & Development Expense		 1.28 1.26 1.25 1.33 1.47 1.50 1.52 1.44 1.41 1.35 1.57
Other Operating Expenses / (Income)		 1.33 8.29 4.50 4.69 5.02 9.00 1.49 5.37 5.59 6.49 6.32
Total Other Income / (Expense), net		 1.37 0.04 -0.02 0.04 0.06 -0.01 0.07 0.18 0.19 0.25 0.17
Interest Expense		 0.04 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Interest & Investment Income		 - - 0.01 0.05 0.07 - 0.08 0.13 0.20 0.23 0.16
Other Income / (Expense), net		 1.41 0.04 -0.01 -0.01 -0.00 -0.19 -0.01 0.06 -0.01 0.02 0.01
Income Tax Expense		 0.03 0.07 0.03 0.03 0.05 0.17 0.04 0.05 0.04 0.17 0.03
Basic Earnings per Share		 $0.07 - $0.02 $0.02 $0.01 $0.01 $0.04 $0.04 $0.05 $0.04 $0.02
Weighted Average Basic Shares Outstanding		 26.00M 25.94M 26.31M 26.66M 26.85M 26.76M 28.02M 29.43M 30.40M 29.68M 31.53M
Diluted Earnings per Share		 $0.06 $0.01 $0.01 $0.02 $0.00 $0.03 $0.04 $0.04 $0.05 $0.03 $0.02
Weighted Average Diluted Shares Outstanding		 27.68M 25.94M 30.14M 29.51M 29.86M 30.02M 31.09M 31.32M 31.82M 31.64M 32.68M
Weighted Average Basic & Diluted Shares Outstanding		 26.03M 26.28M 26.63M 26.71M 27.10M 27.90M 29.03M 30.17M 30.73M 31.15M 32.42M

Annual Cash Flow Statements for Crexendo

This table details how cash moves in and out of Crexendo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -1.41 -0.88 0.66 0.57 2.33 26 -10 -1.99 7.17 7.85 13
Net Cash From Operating Activities		 -2.97 -1.13 0.29 0.45 1.64 0.65 -1.01 -0.41 3.50 6.28 9.30
Net Cash From Continuing Operating Activities		 -2.79 -0.94 0.41 0.41 1.64 13 3.88 -0.59 5.25 6.28 9.30
Net Income / (Loss) Continuing Operations		 -4.54 -2.79 -0.93 -0.22 1.14 7.94 2.45 -35 -0.36 1.68 5.07
Consolidated Net Income / (Loss)		 -4.54 -2.79 -0.93 -0.22 1.14 7.94 2.45 -35 -0.36 1.68 5.07
Depreciation Expense		 0.27 0.15 0.11 0.09 0.09 0.26 1.63 2.75 3.57 3.33 3.30
Non-Cash Adjustments To Reconcile Net Income		 1.47 0.93 0.99 0.46 -0.17 4.91 0.60 32 3.15 1.72 1.06
Changes in Operating Assets and Liabilities, net		 -0.40 0.36 0.09 0.13 0.57 -0.35 -0.79 -0.11 -1.11 -0.44 -0.13
Net Cash From Investing Activities		 -0.00 0.01 0.25 -0.01 -0.07 14 -9.87 -1.70 3.70 -0.03 -0.02
Net Cash From Continuing Investing Activities		 -0.00 0.01 0.25 -0.01 -0.07 -0.92 -9.87 -1.70 3.70 -0.03 -0.02
Purchase of Property, Plant & Equipment		 -0.03 - - - - - -0.10 -0.29 -0.09 -0.03 -0.02
Net Cash From Financing Activities		 1.57 0.24 0.12 0.12 0.77 -0.92 0.65 -0.05 -2.31 1.60 3.88
Net Cash From Continuing Financing Activities		 1.57 0.24 0.12 0.12 0.77 14 0.65 0.24 -1.78 1.60 3.88
Repayment of Debt		 -0.11 -0.16 -1.16 -0.16 -0.08 -0.09 -0.17 -0.09 -2.34 -0.53 -0.50
Other Financing Activities, net		 1.68 0.40 1.16 0.16 0.85 1.99 0.82 0.71 0.41 2.13 4.38
Effect of Exchange Rate Changes		 - - - - - 0.00 0.01 - - -0.01 0.02
Cash Interest Paid		 - - 0.01 0.01 0.01 0.07 0.08 0.08 0.12 0.03 0.02
Cash Income Taxes Paid		 0.00 0.00 0.01 0.02 0.01 0.01 -0.02 -0.12 -0.12 -0.30 -0.36

Quarterly Cash Flow Statements for Crexendo

This table details how cash moves in and out of Crexendo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 4.38 4.06 0.69 2.57 1.84 12 3.01 2.24 5.12 2.81 -24
Net Cash From Operating Activities		 1.56 2.61 -0.17 2.65 1.62 2.18 1.24 1.30 4.42 2.35 2.04
Net Cash From Continuing Operating Activities		 2.41 3.52 -0.17 2.65 1.62 11 1.24 1.30 4.42 2.35 2.04
Net Income / (Loss) Continuing Operations		 2.55 -0.79 0.43 0.59 0.15 2.85 1.17 1.23 1.45 1.22 0.58
Consolidated Net Income / (Loss)		 2.55 -0.79 0.43 0.59 0.15 2.85 1.17 1.23 1.45 1.22 0.58
Depreciation Expense		 0.89 0.88 0.84 0.84 0.83 0.83 0.77 0.86 0.84 0.83 1.17
Non-Cash Adjustments To Reconcile Net Income		 -1.26 3.21 0.25 0.35 0.18 2.76 0.32 0.53 -0.26 0.47 0.73
Changes in Operating Assets and Liabilities, net		 0.23 0.21 -1.69 0.88 0.46 4.10 -1.03 -1.32 2.38 -0.17 -0.44
Net Cash From Investing Activities		 3.79 - 0.00 - - -0.03 0.00 -0.02 - - -26
Net Cash From Continuing Investing Activities		 3.79 - 0.00 - - -0.03 0.00 -0.02 - - -26
Acquisitions		 - - - - - - 0.00 - - - -26
Net Cash From Financing Activities		 -1.84 0.02 0.86 -0.08 0.23 0.58 1.76 0.93 0.73 0.46 0.06
Net Cash From Continuing Financing Activities		 -1.84 0.55 0.86 -0.08 0.23 1.07 1.76 0.93 0.73 0.46 0.06
Repayment of Debt		 -1.87 -0.19 -0.13 -0.13 -0.13 -0.12 -0.14 -0.12 -0.12 -0.12 -0.11
Other Financing Activities, net		 0.03 0.66 0.99 0.05 0.37 1.19 1.90 1.05 0.85 0.58 0.18
Effect of Exchange Rate Changes		 - - 0.00 -0.00 -0.01 - 0.01 0.03 -0.02 -0.00 -0.02
Cash Interest Paid		 0.04 0.00 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.00 0.00
Cash Income Taxes Paid		 -0.01 -0.03 0.00 -0.19 0.39 -0.10 -0.01 -0.23 0.56 -0.68 0.00

Annual Balance Sheets for Crexendo

This table presents Crexendo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 5.66 3.53 3.74 4.55 7.78 31 77 56 56 65 78
Total Current Assets		 3.30 2.05 2.64 3.33 5.73 20 12 12 17 27 42
Cash & Equivalents		 1.50 0.62 1.28 1.85 4.18 18 7.47 5.48 10 18 31
Note & Lease Receivable		 - - - 0.07 - - - 0.64 0.86 1.05 1.42
Accounts Receivable		 0.36 0.35 0.37 0.42 0.38 0.54 2.18 3.30 3.48 4.35 4.91
Inventories, net		 0.13 0.17 0.13 0.27 0.38 0.50 0.23 0.68 0.38 0.39 0.45
Prepaid Expenses		 1.05 0.69 0.25 0.24 0.14 0.19 0.36 0.43 0.51 0.88 0.89
Current Deferred & Refundable Income Taxes		 - - 0.00 0.00 0.00 0.00 0.01 - 0.00 0.08 0.23
Other Current Assets		 0.15 0.13 0.51 0.38 0.54 0.87 1.32 1.83 1.38 1.94 2.61
Plant, Property, & Equipment, net		 0.03 0.02 0.01 0.12 0.16 2.73 2.99 3.32 0.67 0.39 0.20
Total Noncurrent Assets		 2.33 1.47 1.09 1.09 1.90 8.19 63 40 39 38 36
Noncurrent Note & Lease Receivables		 0.32 0.04 0.03 0.18 0.57 0.91 0.94 1.26 1.77 2.40 3.22
Goodwill		 0.27 0.27 0.27 0.27 0.27 0.27 37 9.45 9.45 9.45 9.45
Intangible Assets		 0.47 0.34 0.24 0.17 0.47 0.25 22 27 24 21 18
Other Noncurrent Operating Assets		 0.71 0.82 0.54 0.46 0.59 0.71 1.54 2.54 3.76 5.28 5.06
Total Liabilities & Shareholders' Equity		 5.66 3.53 3.74 4.55 7.78 31 77 56 56 65 78
Total Liabilities		 3.46 3.02 2.11 2.55 3.40 4.94 11 14 12 14 14
Total Current Liabilities		 2.30 1.99 1.72 2.01 2.89 2.56 11 10 10 12 12
Short-Term Debt		 0.06 0.07 0.07 0.06 0.18 0.07 1.87 0.42 0.46 0.48 0.11
Accounts Payable		 0.08 0.12 0.08 0.16 0.09 0.06 0.48 1.21 0.77 1.00 0.65
Accrued Expenses		 0.81 1.00 0.96 1.13 1.75 1.63 4.90 4.89 5.95 6.99 8.39
Current Deferred & Payable Income Tax Liabilities		 0.48 0.01 - - - 0.00 0.02 0.08 0.05 0.04 0.15
Other Current Liabilities		 0.10 - 0.61 0.67 0.87 0.81 3.30 3.80 3.03 3.58 3.02
Total Noncurrent Liabilities		 1.16 1.03 0.38 0.54 0.51 2.38 0.65 3.78 1.29 1.43 1.54
Capital Lease Obligations		 - - 0.00 - - - - - 0.47 1.02 0.53
Other Noncurrent Operating Liabilities		 0.11 0.02 0.37 0.54 0.51 0.51 0.65 1.10 0.22 0.30 1.01
Total Equity & Noncontrolling Interests		 2.20 0.52 1.63 2.00 4.39 26 66 41 45 51 64
Total Preferred & Common Equity		 2.20 0.52 1.63 2.00 4.39 26 66 41 45 51 64
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 2.20 0.52 1.63 2.00 4.39 26 66 41 45 51 64
Common Stock		 58 59 61 61 62 76 118 129 133 138 145
Retained Earnings		 -55 -58 -59 -59 -58 -50 -53 -88 -88 -87 -82
Accumulated Other Comprehensive Income / (Loss)		 - - - - - 0.00 0.01 0.19 0.17 0.16 0.18

Quarterly Balance Sheets for Crexendo

This table presents Crexendo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 55 57 60 62 67 71 76 91
Total Current Assets		 16 19 22 24 30 35 39 23
Cash & Equivalents		 7.74 11 14 15 21 23 29 7.25
Note & Lease Receivable		 0.81 0.88 0.94 0.98 1.14 1.19 1.34 2.65
Accounts Receivable		 3.87 4.22 3.99 3.75 4.06 5.62 4.75 6.37
Inventories, net		 0.47 0.38 0.55 0.52 0.58 0.62 0.64 1.17
Prepaid Expenses		 0.99 0.90 1.04 1.33 0.99 1.30 1.47 1.33
Current Deferred & Refundable Income Taxes		 - - 0.08 0.05 0.04 0.23 0.26 0.20
Other Current Assets		 1.73 1.62 1.67 1.78 2.13 2.23 2.29 4.05
Plant, Property, & Equipment, net		 0.76 0.59 0.51 0.44 0.33 0.29 0.24 0.44
Total Noncurrent Assets		 39 38 37 38 37 36 36 68
Noncurrent Note & Lease Receivables		 1.67 1.87 1.99 2.23 2.55 2.66 3.15 5.52
Goodwill		 9.45 9.45 9.45 9.45 9.45 9.45 9.45 14
Intangible Assets		 24 23 22 21 20 19 19 40
Other Noncurrent Operating Assets		 3.49 3.71 3.77 4.99 5.15 4.90 5.15 7.95
Total Liabilities & Shareholders' Equity		 55 57 60 62 67 71 76 91
Total Liabilities		 12 11 11 13 12 13 15 19
Total Current Liabilities		 10 9.61 10 11 11 12 14 17
Short-Term Debt		 0.45 0.46 0.47 0.47 0.48 0.36 0.24 0.00
Accounts Payable		 0.87 0.62 0.91 0.75 0.86 0.52 0.74 2.64
Accrued Expenses		 5.05 5.00 5.92 6.67 6.44 7.47 8.06 9.89
Current Deferred & Payable Income Tax Liabilities		 0.07 0.08 0.00 0.00 0.04 0.04 0.04 0.15
Other Current Liabilities		 3.65 3.45 3.15 3.26 3.30 3.71 4.53 4.11
Total Noncurrent Liabilities		 1.55 1.09 1.01 1.63 1.11 0.96 1.01 1.78
Capital Lease Obligations		 - - - - 0.91 0.78 0.66 0.40
Other Noncurrent Operating Liabilities		 0.84 0.61 0.65 1.40 0.21 0.18 0.36 1.38
Total Equity & Noncontrolling Interests		 44 47 48 49 55 58 61 73
Total Preferred & Common Equity		 44 47 48 49 55 58 61 73
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Total Common Equity		 44 47 48 49 55 58 61 73
Common Stock		 132 135 135 137 141 142 144 154
Retained Earnings		 -89 -88 -87 -87 -86 -84 -83 -81
Accumulated Other Comprehensive Income / (Loss)		 0.19 0.17 0.17 0.15 0.17 0.21 0.19 0.17

Annual Metrics And Ratios for Crexendo

This table displays calculated financial ratios and metrics derived from Crexendo's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 13,227,289.00 13,413,556.00 14,275,555.00 14,394,113.00 14,714,576.00 17,963,234.00 21,685,214.00 22,756,167.00 26,034,604.00 - 30,731,048.00
DEI Adjusted Shares Outstanding		 13,227,289.00 13,413,556.00 14,275,555.00 14,394,113.00 14,714,576.00 17,963,234.00 21,685,214.00 22,756,167.00 26,034,604.00 - 30,731,048.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.34 -0.21 -0.07 -0.02 0.08 -0.12 -0.11 -1.56 -0.01 - 0.17
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 3.02% 16.57% 11.71% 16.89% 21.23% 127.03% -14.29% 33.68% 41.66% 14.36% 12.05%
EBITDA Growth		 27.57% 43.67% 74.63% 80.83% 1,221.62% 71.16% -156.36% -2,676.85% 110.25% 47.84% 58.71%
EBIT Growth		 29.43% 41.59% 72.79% 71.92% 667.00% 62.73% -250.93% -1,176.87% 99.58% 1,252.32% 173.16%
NOPAT Growth		 26.67% 42.90% 73.43% 71.93% 882.98% -291.45% 9.00% -1,230.68% 95.48% 236.96% 173.45%
Net Income Growth		 28.78% 38.52% 66.73% 76.00% 610.76% 597.10% -130.79% -1,348.38% 98.98% 563.26% 202.39%
EPS Growth		 38.60% 40.00% 66.67% 71.43% 450.00% 557.14% -126.09% -1,183.33% 99.35% 700.00% 166.67%
Operating Cash Flow Growth		 33.14% 62.14% 126.11% 53.74% 262.39% -60.50% -255.49% 59.15% 951.34% 79.59% 47.95%
Free Cash Flow Firm Growth		 -7.12% 63.64% 98.96% 770.31% 1,000.29% -1,361.43% -338.98% 90.57% 143.04% 21.34% 140.01%
Invested Capital Growth		 -0.97% -46.09% -60.51% -70.34% 190.72% 3,456.38% 501.64% -35.21% -8.45% -2.67% -5.02%
Revenue Q/Q Growth		 1.56% 2.66% 4.82% 2.44% 4.57% 107.54% -29.43% 6.97% 5.39% 3.53% 2.74%
EBITDA Q/Q Growth		 8.88% 25.72% 43.79% -37.04% 23.02% 65.32% -120,000.00% -2,424.60% 111.52% 6.36% 7.95%
EBIT Q/Q Growth		 9.02% 23.30% 41.79% -18.02% 25.52% 75.54% -184.69% -832.74% 99.55% 26.00% 14.17%
NOPAT Q/Q Growth		 9.02% 22.84% 41.93% -11.35% 24.08% -300.80% -48.76% -942.72% 95.35% 42.77% 11.83%
Net Income Q/Q Growth		 9.56% 21.02% 37.48% -21.86% 26.14% 688.48% -145.98% -937.29% 98.90% 36.23% 16.31%
EPS Q/Q Growth		 14.63% 25.00% 30.00% -100.00% 40.00% 666.67% -138.71% -1,000.00% 99.31% 50.00% 0.00%
Operating Cash Flow Q/Q Growth		 12.56% 35.36% 238.68% -3.21% 30.10% -28.43% -304.02% 87.15% 11.40% -6.47% 1.86%
Free Cash Flow Firm Q/Q Growth		 -0.93% 45.43% 93.15% 128.09% 4.32% -402.78% 10.27% 3.60% 207.35% -26.84% 22.91%
Invested Capital Q/Q Growth		 50.00% 8.38% 395.45% -59.92% 14.17% 171.64% -0.48% -38.18% -3.56% 0.31% -1.71%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 54.28% 60.25% 67.94% 67.93% 69.86% 84.91% 94.57% 95.64% 93.74% 94.72% 95.84%
EBITDA Margin		 -51.78% -25.02% -5.68% -0.93% 8.62% 6.50% -4.28% -88.81% 6.42% 8.31% 11.81%
Operating Margin		 -61.86% -30.30% -7.21% -1.73% 7.86% 3.02% -10.00% -99.57% -3.17% 3.00% 6.88%
EBIT Margin		 -58.15% -29.14% -7.10% -1.70% 7.97% 5.71% -10.06% -96.12% -0.28% 2.86% 6.97%
Profit (Net Income) Margin		 -58.05% -30.62% -9.12% -1.87% 7.89% 24.23% -8.70% -94.30% -0.68% 2.76% 7.44%
Tax Burden Percent		 99.74% 100.43% 100.76% 107.21% 99.48% 418.11% 84.02% 97.89% 137.12% 88.78% 94.41%
Interest Burden Percent		 100.09% 104.63% 127.52% 102.46% 99.48% 101.39% 102.94% 100.22% 174.83% 108.56% 113.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.52% 318.11% 0.00% 0.00% 0.00% 11.22% 5.59%
Return on Invested Capital (ROIC)		 -219.46% -163.63% -88.97% -68.02% 595.81% -41.93% -5.59% -52.65% -3.16% 4.59% 13.04%
ROIC Less NNEP Spread (ROIC-NNEP)		 -156.43% 319.69% -5.09% -63.10% 595.47% -143.76% -1.11% 179.39% -17.82% 4.13% 10.32%
Return on Net Nonoperating Assets (RNNOA)		 84.87% -41.74% 2.35% 55.73% -560.14% 94.59% 0.26% -13.30% 2.32% -1.09% -4.24%
Return on Equity (ROE)		 -134.59% -205.37% -86.62% -12.29% 35.67% 52.67% -5.33% -65.95% -0.84% 3.49% 8.80%
Cash Return on Invested Capital (CROIC)		 -218.48% -103.73% -2.22% 40.47% 498.18% -230.99% -148.58% -9.91% 5.66% 7.29% 18.19%
Operating Return on Assets (OROA)		 -69.06% -57.80% -19.89% -4.90% 18.67% 9.73% -5.24% -54.37% -0.27% 2.87% 6.67%
Return on Assets (ROA)		 -68.94% -60.74% -25.56% -5.38% 18.47% 41.26% -4.53% -53.34% -0.65% 2.77% 7.11%
Return on Common Equity (ROCE)		 -134.59% -205.37% -86.62% -12.29% 35.67% 52.67% -5.33% -65.95% -0.84% 3.49% 8.80%
Return on Equity Simple (ROE_SIMPLE)		 -206.03% -542.14% -56.99% -11.15% 25.96% 30.82% -3.71% -85.42% -0.81% 3.26% 0.00%
Net Operating Profit after Tax (NOPAT)		 -3.39 -1.93 -0.51 -0.14 1.13 -2.16 -1.97 -26 -1.18 1.62 4.43
NOPAT Margin		 -43.30% -21.21% -5.04% -1.21% 7.82% -6.60% -7.00% -69.70% -2.22% 2.66% 6.50%
Net Nonoperating Expense Percent (NNEP)		 -63.03% -483.32% -83.88% -4.92% 0.33% 101.83% -4.48% -232.04% 14.66% 0.45% 2.72%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -2.56% 3.05% 6.87%
Cost of Revenue to Revenue		 45.72% 39.75% 32.06% 32.07% 30.14% 15.09% 5.43% 4.36% 6.26% 5.28% 4.16%
SG&A Expenses to Revenue		 74.93% 53.73% 39.97% 34.36% 29.34% 15.58% 37.68% 34.36% 25.93% 22.73% 21.60%
R&D to Revenue		 9.96% 9.06% 7.36% 6.73% 5.91% 3.63% 4.97% 10.53% 9.14% 9.13% 8.39%
Operating Expenses to Revenue		 116.13% 90.55% 75.14% 69.66% 62.00% 78.86% 104.57% 195.21% 96.91% 91.72% 88.96%
Earnings before Interest and Taxes (EBIT)		 -4.55 -2.66 -0.72 -0.20 1.15 1.87 -2.83 -36 -0.15 1.74 4.75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -4.05 -2.28 -0.58 -0.11 1.25 2.13 -1.20 -33 3.42 5.05 8.05
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 8.97 38.93 13.09 12.82 14.11 4.78 1.63 1.04 2.83 2.76 3.12
Price to Tangible Book Value (P/TBV)		 13.49 0.00 19.07 16.43 16.96 4.88 15.78 8.16 10.88 6.61 5.45
Price to Revenue (P/Rev)		 2.53 2.20 2.09 2.15 4.29 3.76 3.82 1.15 2.37 2.33 2.92
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 54.35 0.00 0.00 0.00 0.00 84.52 39.21
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.06% 0.41% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 1.84% 0.00% 0.00% 0.00% 0.00% 1.18% 2.55%
Enterprise Value to Invested Capital (EV/IC)		 12.44 24.59 61.27 244.78 204.96 10.72 1.69 1.04 3.28 3.59 5.08
Enterprise Value to Revenue (EV/Rev)		 2.44 2.23 1.97 1.99 4.00 3.28 3.62 1.08 2.21 2.06 2.47
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 46.42 50.44 0.00 0.00 34.36 24.77 20.89
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 50.22 57.39 0.00 0.00 0.00 71.93 35.37
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 51.19 0.00 0.00 0.00 0.00 77.29 37.96
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 68.15 52.53 35.29 166.14 0.00 0.00 33.56 19.92 18.08
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 276.74 61.22 0.00 0.00 0.00 55.38 48.64 27.22
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.46 2.00 0.05 0.03 0.04 0.08 0.03 0.07 0.03 0.03 0.01
Long-Term Debt to Equity		 0.44 1.88 0.01 0.00 0.00 0.07 0.00 0.06 0.02 0.02 0.01
Financial Leverage		 -0.54 -0.13 -0.46 -0.88 -0.94 -0.66 -0.23 -0.07 -0.13 -0.26 -0.41
Leverage Ratio		 1.95 3.38 3.39 2.28 1.93 1.28 1.18 1.24 1.30 1.26 1.24
Compound Leverage Factor		 1.95 3.54 4.32 2.34 1.92 1.29 1.21 1.24 2.27 1.37 1.40
Debt to Total Capital		 31.68% 66.71% 4.62% 2.72% 3.84% 7.02% 2.76% 6.97% 3.30% 3.04% 1.00%
Short-Term Debt to Total Capital		 1.77% 4.27% 4.04% 2.72% 3.84% 0.26% 2.76% 0.94% 0.99% 0.90% 0.18%
Long-Term Debt to Total Capital		 29.91% 62.44% 0.59% 0.00% 0.00% 6.76% 0.00% 6.03% 2.31% 2.14% 0.82%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 68.32% 33.29% 95.38% 97.28% 96.16% 92.98% 97.24% 93.03% 96.70% 96.96% 99.00%
Debt to EBITDA		 -0.25 -0.45 -0.14 -0.50 0.14 0.91 -1.56 -0.09 0.45 0.32 0.08
Net Debt to EBITDA		 0.16 -0.14 2.25 17.14 -3.30 -7.38 4.66 0.07 -2.58 -3.28 -3.82
Long-Term Debt to EBITDA		 -0.24 -0.42 -0.02 0.00 0.00 0.88 0.00 -0.08 0.31 0.22 0.07
Debt to NOPAT		 -0.30 -0.53 -0.15 -0.39 0.16 -0.90 -0.95 -0.12 -1.29 1.00 0.15
Net Debt to NOPAT		 0.20 -0.16 2.54 13.20 -3.64 7.28 2.84 0.09 7.46 -10.24 -6.94
Long-Term Debt to NOPAT		 -0.28 -0.50 -0.02 0.00 0.00 -0.87 0.00 -0.10 -0.90 0.70 0.12
Altman Z-Score		 -11.33 -18.96 -13.62 -9.35 3.28 14.62 5.05 -1.81 5.44 5.72 8.67
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.43 1.03 1.53 1.66 1.99 7.72 1.09 1.19 1.65 2.22 3.40
Quick Ratio		 0.81 0.48 0.96 1.16 1.58 7.07 0.91 0.91 1.43 1.95 3.06
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -3.37 -1.23 -0.01 0.09 0.94 -12 -52 -4.93 2.12 2.57 6.18
Operating Cash Flow to CapEx		 -11,896.00% 0.00% 0.00% 0.00% 0.00% 0.00% -996.04% -142.21% 0.00% 23,274.07% 51,650.00%
Free Cash Flow to Firm to Interest Expense		 -120.44 -8.88 -0.06 7.15 78.67 0.00 -622.33 -63.17 18.44 61.27 325.05
Operating Cash Flow to Interest Expense		 -106.21 -8.16 1.41 37.67 136.50 0.00 -11.98 -5.27 30.43 149.62 489.32
Operating Cash Flow Less CapEx to Interest Expense		 -107.11 -8.16 1.41 37.67 136.50 0.00 -13.18 -8.97 62.60 148.98 488.37
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.19 1.98 2.80 2.87 2.34 1.70 0.52 0.57 0.95 1.00 0.96
Accounts Receivable Turnover		 17.25 25.69 28.38 30.11 36.14 71.40 20.69 13.72 15.71 15.54 14.71
Inventory Turnover		 34.73 23.85 21.70 19.05 13.35 11.17 4.15 3.60 6.28 8.30 6.69
Fixed Asset Turnover		 154.91 357.61 783.62 180.42 103.48 22.69 9.82 11.91 26.70 114.36 231.47
Accounts Payable Turnover		 58.16 37.76 33.50 32.64 36.11 69.68 5.73 1.95 3.37 3.63 3.43
Days Sales Outstanding (DSO)		 21.16 14.21 12.86 12.12 10.10 5.11 17.64 26.60 23.23 23.48 24.80
Days Inventory Outstanding (DIO)		 10.51 15.30 16.82 19.16 27.35 32.69 87.96 101.45 58.13 43.99 54.52
Days Payable Outstanding (DPO)		 6.28 9.67 10.90 11.18 10.11 5.24 63.67 187.52 108.21 100.59 106.35
Cash Conversion Cycle (CCC)		 25.39 19.85 18.79 20.10 27.34 32.56 41.93 -59.46 -26.84 -33.11 -27.02
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1.54 0.83 0.33 0.10 0.28 10 60 39 36 35 33
Invested Capital Turnover		 5.07 7.71 17.64 56.17 76.18 6.36 0.80 0.76 1.42 1.72 2.01
Increase / (Decrease) in Invested Capital		 -0.02 -0.71 -0.50 -0.23 0.19 9.75 50 -21 -3.30 -0.95 -1.75
Enterprise Value (EV)		 19 20 20 24 58 107 102 41 117 125 168
Market Capitalization		 20 20 21 26 62 123 107 43 126 142 199
Book Value per Share		 $0.17 $0.04 $0.11 $0.14 $0.30 $1.43 $3.04 $1.82 $1.71 $1.90 $2.08
Tangible Book Value per Share		 $0.11 ($0.01) $0.08 $0.11 $0.25 $1.41 $0.31 $0.23 $0.45 $0.79 $1.19
Total Capital		 3.23 1.55 1.71 2.06 4.56 28 68 45 46 53 64
Total Debt		 1.02 1.03 0.08 0.06 0.18 1.94 1.87 3.11 1.52 1.61 0.64
Total Long-Term Debt		 0.97 0.97 0.01 0.00 0.00 1.87 0.00 2.69 1.07 1.14 0.53
Net Debt		 -0.67 0.31 -1.30 -1.90 -4.11 -16 -5.60 -2.37 -8.83 -17 -31
Capital Expenditures (CapEx)		 0.03 0.00 0.00 0.00 0.00 0.00 0.10 0.29 -3.70 0.03 0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.55 -0.60 -0.39 -0.57 -1.26 -0.39 -4.61 -3.10 -3.20 -2.93 -1.70
Debt-free Net Working Capital (DFNWC)		 1.06 0.12 0.99 1.38 3.02 17 2.86 2.38 7.15 15 30
Net Working Capital (NWC)		 1.00 0.06 0.92 1.32 2.85 17 0.99 1.96 6.69 15 30
Net Nonoperating Expense (NNE)		 1.15 0.86 0.42 0.08 -0.01 -10 0.48 9.24 -0.82 -0.06 -0.64
Net Nonoperating Obligations (NNO)		 -0.67 0.31 -1.30 -1.90 -4.11 -16 -5.60 -2.37 -8.83 -17 -31
Total Depreciation and Amortization (D&A)		 0.50 0.38 0.14 0.09 0.09 0.26 1.63 2.75 3.57 3.31 3.30
Debt-free, Cash-free Net Working Capital to Revenue		 -7.08% -6.54% -3.85% -4.80% -8.73% -1.19% -16.40% -8.24% -6.02% -4.81% -2.49%
Debt-free Net Working Capital to Revenue		 13.49% 1.35% 9.72% 11.57% 20.92% 52.75% 10.18% 6.33% 13.43% 25.09% 43.54%
Net Working Capital to Revenue		 12.76% 0.63% 9.04% 11.10% 19.71% 52.54% 3.52% 5.22% 12.57% 24.31% 43.38%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.35) ($0.21) ($0.07) ($0.02) $0.08 $0.00 ($0.12) $0.00 ($0.01) $0.06 $0.17
Adjusted Weighted Average Basic Shares Outstanding		 12.96M 13.36M 13.94M 14.33M 14.57M 0.00 20.28M 0.00 25.94M 26.76M 29.68M
Adjusted Diluted Earnings per Share		 ($0.35) ($0.21) ($0.07) ($0.02) $0.07 $0.00 ($0.12) $0.00 ($0.01) $0.06 $0.16
Adjusted Weighted Average Diluted Shares Outstanding		 12.96M 13.36M 13.94M 14.33M 15.56M 0.00 20.28M 0.00 25.94M 30.02M 31.64M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.25M 13.65M 14.29M 14.39M 14.90M 0.00 20.28M 0.00 26.28M 27.90M 31.15M
Normalized Net Operating Profit after Tax (NOPAT)		 -3.39 -1.93 -0.51 -0.14 1.13 0.69 -1.97 -3.30 -1.18 1.62 4.43
Normalized NOPAT Margin		 -43.30% -21.21% -5.04% -1.21% 7.82% 2.12% -7.00% -8.79% -2.22% 2.66% 6.50%
Pre Tax Income Margin		 -58.20% -30.49% -9.05% -1.75% 7.93% 5.79% -10.36% -96.33% -0.50% 3.11% 7.88%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -162.46 -19.25 -3.46 -16.92 95.92 0.00 -33.65 -462.78 -1.31 41.43 250.16
NOPAT to Interest Expense		 -120.98 -14.02 -2.46 -12.02 94.09 0.00 -23.42 -335.57 -10.28 38.55 233.05
EBIT Less CapEx to Interest Expense		 -163.36 -19.25 -3.46 -16.92 95.92 0.00 -34.86 -466.49 30.86 40.79 249.21
NOPAT Less CapEx to Interest Expense		 -121.87 -14.02 -2.46 -12.02 94.09 0.00 -24.62 -339.27 21.89 37.91 232.11
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1.30% -35.91% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1.30% -35.91% 0.00% 0.00%

Quarterly Metrics And Ratios for Crexendo

This table displays calculated financial ratios and metrics derived from Crexendo's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 25,975,804.00 26,034,604.00 26,284,202.00 26,628,022.00 26,714,907.00 - 27,901,072.00 29,030,543.00 30,169,531.00 30,731,048.00 31,152,603.00
DEI Adjusted Shares Outstanding		 25,975,804.00 26,034,604.00 26,284,202.00 26,628,022.00 26,714,907.00 - 27,901,072.00 29,030,543.00 30,169,531.00 30,731,048.00 31,152,603.00
DEI Earnings Per Adjusted Shares Outstanding		 0.07 0.00 0.02 0.02 0.01 - 0.04 0.04 0.05 0.04 0.02
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 52.33% 23.79% 14.37% 15.90% 12.64% 14.66% 12.40% 12.71% 11.97% 11.21% 28.98%
EBITDA Growth		 3,191.86% 102.98% 315.30% 243.66% -63.86% 31.56% 45.99% 43.08% 122.27% 42.60% -15.38%
EBIT Growth		 350.07% 100.24% 130.94% 217.42% -92.56% 448.75% 143.07% 102.44% 882.58% 104.24% -60.70%
NOPAT Growth		 193.77% 100.03% 141.27% 253.23% -71.16% 7,133.56% 143.75% 91.45% 1,130.62% 94.44% -62.20%
Net Income Growth		 344.83% 100.19% 127.43% 207.89% -91.31% 731.15% 169.82% 109.52% 879.73% 140.24% -50.64%
EPS Growth		 300.00% 100.70% 116.67% 200.00% -100.00% 200.00% 300.00% 100.00% 0.00% 0.00% -50.00%
Operating Cash Flow Growth		 3,158.82% 15.88% 89.32% 201.02% 3.91% -16.65% 845.78% -51.17% 172.49% 7.81% 64.54%
Free Cash Flow Firm Growth		 987.99% 211.23% -79.76% -89.09% -90.61% -57.33% -42.80% -82.53% -6.18% 87.15% -1,365.52%
Invested Capital Growth		 -41.31% -8.45% -9.16% -5.76% -6.42% -2.67% -3.45% 1.66% -3.07% -5.02% 86.08%
Revenue Q/Q Growth		 9.50% 2.09% 0.86% 2.79% 6.41% 3.92% -1.13% 3.08% 5.71% 3.22% 14.67%
EBITDA Q/Q Growth		 548.54% -64.01% 36.78% 7.64% -31.80% 22.95% 37.28% 5.49% 5.95% -7.07% -18.54%
EBIT Q/Q Growth		 463.32% -95.49% 486.25% 22.17% -76.96% 118.41% 101.41% 1.75% 11.81% -10.87% -61.25%
NOPAT Q/Q Growth		 198.67% -98.23% 7,079.69% 21.95% -81.43% 344.82% 116.17% -4.21% 19.38% -21.34% -57.97%
Net Income Q/Q Growth		 412.66% -96.42% 611.48% 35.48% -74.83% 242.57% 130.97% 5.21% 17.69% -16.00% -52.55%
EPS Q/Q Growth		 400.00% -83.33% 0.00% 100.00% -100.00% 0.00% 33.33% 0.00% 25.00% -40.00% -33.33%
Operating Cash Flow Q/Q Growth		 77.07% 67.44% -106.36% 1,697.59% -38.88% 34.30% -43.13% 4.60% 241.08% -46.86% -13.21%
Free Cash Flow Firm Q/Q Growth		 6.26% -87.50% 25.42% -34.53% -8.52% -43.20% 61.88% -80.01% 391.41% 17.69% -1,194.67%
Invested Capital Q/Q Growth		 -1.21% -3.56% 2.44% -3.44% -1.90% 0.31% 1.61% 1.67% -6.46% -1.71% 99.06%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 70.48% 117.54% 94.89% 95.26% 93.08% 116.18% 74.55% 95.85% 94.92% 96.34% 91.92%
EBITDA Margin		 19.17% 6.76% 9.16% 9.59% 6.15% 7.75% 11.90% 12.18% 12.21% 10.99% 7.81%
Operating Margin		 2.62% 0.27% 3.38% 3.95% 0.86% 3.85% 7.16% 6.66% 7.46% 6.27% 2.12%
EBIT Margin		 12.78% 0.56% 3.28% 3.90% 0.84% 2.70% 7.10% 7.01% 7.41% 6.40% 2.16%
Profit (Net Income) Margin		 12.28% 0.43% 3.04% 4.00% 0.95% 3.12% 7.29% 7.44% 8.29% 6.74% 2.79%
Tax Burden Percent		 98.10% 78.21% 94.14% 95.61% 76.29% 81.91% 96.38% 96.25% 97.12% 88.07% 95.22%
Interest Burden Percent		 97.97% 97.50% 98.29% 107.33% 146.97% 141.00% 106.58% 110.34% 115.11% 119.64% 135.49%
Effective Tax Rate		 1.90% 83.33% 5.86% 4.39% 23.71% 26.82% 3.62% 3.75% 2.88% 11.93% 4.78%
Return on Invested Capital (ROIC)		 2.59% 0.06% 4.55% 5.90% 1.08% 4.86% 12.00% 11.59% 14.05% 11.08% 2.91%
ROIC Less NNEP Spread (ROIC-NNEP)		 -25.53% -0.91% 4.93% 5.49% 0.66% 4.48% 11.58% 10.62% 13.19% 10.15% 1.72%
Return on Net Nonoperating Assets (RNNOA)		 2.23% 0.12% -0.60% -1.00% -0.15% -1.18% -3.40% -3.50% -5.05% -4.17% -0.36%
Return on Equity (ROE)		 4.81% 0.18% 3.95% 4.90% 0.93% 3.68% 8.60% 8.09% 9.00% 6.91% 2.55%
Cash Return on Invested Capital (CROIC)		 1.38% 5.66% 10.47% 9.73% 9.65% 7.29% 9.83% 6.16% 14.69% 18.19% -52.79%
Operating Return on Assets (OROA)		 9.80% 0.54% 3.25% 3.91% 0.84% 2.72% 7.12% 6.90% 7.12% 6.12% 1.98%
Return on Assets (ROA)		 9.42% 0.41% 3.01% 4.01% 0.95% 3.14% 7.31% 7.33% 7.96% 6.45% 2.56%
Return on Common Equity (ROCE)		 4.81% 0.18% 3.95% 4.90% 0.93% 3.68% 8.60% 8.09% 9.00% 6.91% 2.55%
Return on Equity Simple (ROE_SIMPLE)		 -75.59% 0.00% 3.54% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 0.36 0.01 0.45 0.55 0.10 0.46 1.11 1.06 1.27 1.00 0.42
NOPAT Margin		 2.57% 0.04% 3.18% 3.78% 0.66% 2.82% 6.90% 6.41% 7.24% 5.52% 2.02%
Net Nonoperating Expense Percent (NNEP)		 28.12% 0.98% -0.39% 0.41% 0.42% 0.38% 0.42% 0.97% 0.86% 0.93% 1.19%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.01% 0.95% 1.13% 0.21% 0.86% 1.96% 1.79% 2.04% 1.55% 0.57%
Cost of Revenue to Revenue		 29.52% -17.54% 5.11% 4.74% 6.92% -16.18% 25.45% 4.15% 5.08% 3.66% 8.08%
SG&A Expenses to Revenue		 23.85% 23.44% 23.07% 23.37% 23.65% 20.97% 21.92% 21.66% 21.60% 21.26% 24.41%
R&D to Revenue		 9.20% 8.86% 8.74% 9.04% 9.43% 9.25% 9.49% 8.68% 8.08% 7.45% 7.57%
Operating Expenses to Revenue		 67.85% 117.28% 91.51% 91.31% 92.22% 112.33% 67.39% 89.19% 87.47% 90.07% 89.80%
Earnings before Interest and Taxes (EBIT)		 1.77 0.08 0.47 0.57 0.13 0.44 1.14 1.16 1.30 1.16 0.45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2.66 0.96 1.31 1.41 0.96 1.26 1.91 2.02 2.14 1.99 1.62
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.25 2.83 2.70 1.74 2.51 2.76 2.46 3.02 3.20 3.12 2.64
Price to Tangible Book Value (P/TBV)		 5.54 10.88 8.71 5.02 6.62 6.61 5.24 5.99 5.90 5.45 10.47
Price to Revenue (P/Rev)		 1.09 2.37 2.30 1.47 2.11 2.33 2.17 2.73 2.96 2.92 2.64
Price to Earnings (P/E)		 0.00 0.00 78.72 30.58 104.78 84.52 56.29 57.62 44.98 39.21 42.92
Dividend Yield		 0.95% 0.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 1.27% 3.27% 0.95% 1.18% 1.78% 1.74% 2.22% 2.55% 2.33%
Enterprise Value to Invested Capital (EV/IC)		 1.30 3.28 3.17 2.00 3.15 3.59 3.28 4.28 5.00 5.08 2.81
Enterprise Value to Revenue (EV/Rev)		 0.96 2.21 2.12 1.24 1.86 2.06 1.85 2.39 2.54 2.47 2.55
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 34.36 21.79 11.20 23.55 24.77 20.46 24.51 22.59 20.89 23.91
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 63.43 24.51 87.09 71.93 48.13 51.33 40.46 35.37 45.64
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 345.42 51.12 100.69 77.29 51.01 55.24 42.53 37.96 49.54
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.36 33.56 23.80 10.66 16.25 19.92 15.10 24.31 18.45 18.08 18.36
Enterprise Value to Free Cash Flow (EV/FCFF)		 69.90 55.38 28.84 19.98 31.49 48.64 32.77 69.98 33.52 27.22 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.03 0.03 0.02 0.02 0.01 0.03 0.03 0.02 0.01 0.01 0.01
Long-Term Debt to Equity		 0.02 0.02 0.01 0.01 0.00 0.02 0.02 0.01 0.01 0.01 0.01
Financial Leverage		 -0.09 -0.13 -0.12 -0.18 -0.23 -0.26 -0.29 -0.33 -0.38 -0.41 -0.21
Leverage Ratio		 1.20 1.30 1.27 1.27 1.26 1.26 1.22 1.23 1.25 1.24 1.24
Compound Leverage Factor		 1.17 1.27 1.25 1.37 1.86 1.78 1.31 1.36 1.44 1.48 1.68
Debt to Total Capital		 2.59% 3.30% 1.96% 1.68% 1.41% 3.04% 2.44% 1.91% 1.43% 1.00% 0.55%
Short-Term Debt to Total Capital		 1.01% 0.99% 0.97% 0.95% 0.94% 0.90% 0.84% 0.60% 0.38% 0.18% 0.00%
Long-Term Debt to Total Capital		 1.58% 2.31% 1.00% 0.73% 0.47% 2.14% 1.60% 1.31% 1.05% 0.82% 0.55%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 97.41% 96.70% 98.04% 98.32% 98.59% 96.96% 97.56% 98.09% 98.57% 99.00% 99.45%
Debt to EBITDA		 -0.04 0.45 0.18 0.13 0.15 0.32 0.24 0.18 0.12 0.08 0.05
Net Debt to EBITDA		 0.22 -2.58 -1.89 -2.02 -3.18 -3.28 -3.50 -3.55 -3.71 -3.82 -0.88
Long-Term Debt to EBITDA		 -0.02 0.31 0.09 0.06 0.05 0.22 0.16 0.12 0.09 0.07 0.05
Debt to NOPAT		 -0.05 -1.29 2.78 0.59 0.65 1.00 0.61 0.41 0.23 0.15 0.11
Net Debt to NOPAT		 0.26 7.46 -30.00 -9.21 -13.59 -10.24 -8.71 -8.01 -6.99 -6.94 -1.83
Long-Term Debt to NOPAT		 -0.03 -0.90 1.41 0.26 0.22 0.70 0.40 0.28 0.17 0.12 0.11
Altman Z-Score		 1.72 5.45 6.12 3.55 5.05 5.65 6.21 7.77 7.86 8.51 5.86
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.55 1.65 1.98 2.10 2.14 2.22 2.71 2.86 2.89 3.40 1.37
Quick Ratio		 1.23 1.43 1.68 1.78 1.81 1.95 2.38 2.50 2.55 3.06 0.97
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 26 3.31 4.15 2.72 2.49 1.41 2.37 0.47 2.33 2.74 -30
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 8,062.96% 0.00% 7,194.44% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 735.50 827.33 319.29 247.05 355.14 128.37 263.82 79.11 777.47 2,744.95 0.00
Operating Cash Flow to Interest Expense		 43.33 653.00 -12.77 241.09 231.57 197.91 137.56 215.83 1,472.33 2,347.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 43.33 653.00 -12.77 241.09 231.57 195.45 137.56 212.83 1,472.33 2,347.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.77 0.95 0.99 1.00 1.00 1.00 1.00 0.98 0.96 0.96 0.92
Accounts Receivable Turnover		 12.78 15.71 13.74 15.12 15.41 15.54 15.13 13.42 15.61 14.71 13.96
Inventory Turnover		 10.77 6.28 6.32 4.87 0.04 8.30 41.08 5.25 4.98 6.69 0.48
Fixed Asset Turnover		 27.11 26.70 75.08 83.65 98.43 114.36 136.25 160.39 196.29 231.47 189.64
Accounts Payable Turnover		 5.43 3.37 4.92 3.74 0.03 3.63 26.56 4.31 3.89 3.43 0.24
Days Sales Outstanding (DSO)		 28.57 23.23 26.56 24.14 23.68 23.48 24.12 27.21 23.38 24.80 26.15
Days Inventory Outstanding (DIO)		 33.89 58.13 57.77 74.94 8,212.50 43.99 8.88 69.56 73.33 54.52 755.08
Days Payable Outstanding (DPO)		 67.26 108.21 74.20 97.53 13,438.64 100.59 13.74 84.69 93.91 106.35 1,515.79
Cash Conversion Cycle (CCC)		 -4.81 -26.84 10.14 1.55 -5,202.45 -33.11 19.27 12.07 2.80 -27.02 -734.56
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 37 36 37 35 35 35 35 36 34 33 66
Invested Capital Turnover		 1.01 1.42 1.43 1.56 1.64 1.72 1.74 1.81 1.94 2.01 1.44
Increase / (Decrease) in Invested Capital		 -26 -3.30 -3.70 -2.16 -2.38 -0.95 -1.27 0.59 -1.07 -1.75 30
Enterprise Value (EV)		 48 117 116 71 109 125 116 154 168 168 185
Market Capitalization		 55 126 126 84 124 142 136 176 196 199 192
Book Value per Share		 $1.68 $1.71 $1.78 $1.81 $1.85 $1.90 $1.98 $2.01 $2.03 $2.08 $2.33
Tangible Book Value per Share		 $0.38 $0.45 $0.55 $0.63 $0.70 $0.79 $0.93 $1.01 $1.10 $1.19 $0.59
Total Capital		 45 46 48 49 50 53 57 59 62 64 73
Total Debt		 1.16 1.52 0.94 0.82 0.71 1.61 1.38 1.14 0.89 0.64 0.40
Total Long-Term Debt		 0.71 1.07 0.48 0.36 0.24 1.14 0.91 0.78 0.66 0.53 0.40
Net Debt		 -6.58 -8.83 -10 -13 -15 -17 -20 -22 -28 -31 -6.85
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.02 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.76 -3.20 -1.15 -1.70 -2.26 -2.93 -1.70 -0.57 -2.62 -1.70 -1.01
Debt-free Net Working Capital (DFNWC)		 5.97 7.15 9.89 12 13 15 20 23 26 30 6.24
Net Working Capital (NWC)		 5.52 6.69 9.43 11 13 15 19 23 26 30 6.24
Net Nonoperating Expense (NNE)		 -1.35 -0.05 0.02 -0.03 -0.05 -0.05 -0.06 -0.17 -0.18 -0.22 -0.16
Net Nonoperating Obligations (NNO)		 -6.58 -8.83 -10 -13 -15 -17 -20 -22 -28 -31 -6.85
Total Depreciation and Amortization (D&A)		 0.89 0.88 0.84 0.84 0.83 0.82 0.77 0.86 0.84 0.83 1.17
Debt-free, Cash-free Net Working Capital to Revenue		 -3.49% -6.02% -2.09% -2.98% -3.85% -4.81% -2.72% -0.88% -3.95% -2.49% -1.39%
Debt-free Net Working Capital to Revenue		 11.84% 13.43% 17.99% 20.89% 22.44% 25.09% 31.16% 35.49% 39.12% 43.54% 8.57%
Net Working Capital to Revenue		 10.94% 12.57% 17.15% 20.07% 21.64% 24.31% 30.40% 34.94% 38.76% 43.38% 8.57%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.07 $0.00 $0.02 $0.02 $0.01 $0.01 $0.04 $0.04 $0.05 $0.04 $0.02
Adjusted Weighted Average Basic Shares Outstanding		 26.00M 25.94M 26.31M 26.66M 26.85M 26.76M 28.02M 29.43M 30.40M 29.68M 31.53M
Adjusted Diluted Earnings per Share		 $0.06 $0.01 $0.01 $0.02 $0.00 $0.03 $0.04 $0.04 $0.05 $0.03 $0.02
Adjusted Weighted Average Diluted Shares Outstanding		 27.68M 25.94M 30.14M 29.51M 29.86M 30.02M 31.09M 31.32M 31.82M 31.64M 32.68M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 26.03M 26.28M 26.63M 26.71M 27.10M 27.90M 29.03M 30.17M 30.73M 31.15M 32.42M
Normalized Net Operating Profit after Tax (NOPAT)		 0.36 0.03 0.45 0.55 0.10 0.46 1.11 1.06 1.27 1.00 0.42
Normalized NOPAT Margin		 2.57% 0.19% 3.18% 3.78% 0.66% 2.82% 6.90% 6.41% 7.24% 5.52% 2.02%
Pre Tax Income Margin		 12.52% 0.55% 3.23% 4.19% 1.24% 3.81% 7.57% 7.73% 8.53% 7.66% 2.93%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 49.25 20.00 36.08 52.09 18.86 39.91 126.67 193.33 432.33 1,156.00 0.00
NOPAT to Interest Expense		 9.92 1.58 34.98 50.41 14.71 41.65 123.15 176.94 422.47 996.95 0.00
EBIT Less CapEx to Interest Expense		 49.25 20.00 36.08 52.09 18.86 37.45 126.67 190.33 432.33 1,156.00 0.00
NOPAT Less CapEx to Interest Expense		 9.92 1.58 34.98 50.41 14.71 39.19 123.15 173.94 422.47 996.95 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -0.78% -35.91% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.78% -35.91% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Crexendo (NASDAQ: CXDO) has shown solid top-line growth over the last several years, but profitability and cash generation have been uneven quarter to quarter. The latest quarter, Q1 2026, showed revenue growth and a small profit, but cash on the balance sheet fell sharply after a large acquisition-related investing outflow. That makes the recent results look like a mix of operating improvement and balance-sheet transition.

  • Revenue is trending higher. Q1 2026 revenue was $20.7 million, up from $18.1 million in Q4 2025 and $16.1 million in Q1 2025. That points to continued sales momentum.
  • Gross profit remains strong. In Q1 2026, gross profit was $19.0 million on just $1.7 million of cost of revenue, suggesting a healthy gross margin profile.
  • The company stayed profitable in Q1 2026. Net income attributable to common shareholders was $578,000, versus $1.218 million in Q4 2025 and $1.171 million in Q1 2025.
  • Operating cash flow was positive. Crexendo generated $2.0 million of operating cash flow in Q1 2026, which indicates the business is still converting operations into cash.
  • Liquidity was still ample at quarter-end. Cash and equivalents were $7.2 million at March 31, 2026, and total current assets of $23.0 million still exceeded current liabilities of $16.8 million.
  • Debt remains low. Short-term debt was zero in Q1 2026, and capital lease obligations were modest at $400,000.
  • Gross margin appears better than a year ago. The company’s cost of revenue as a percentage of sales was far lower in 2026 than in early 2025, when Q1 2025 cost of revenue was much heavier.
  • Quarterly earnings are still relatively small. Q1 2026 diluted EPS was only $0.02, so the business is profitable but not yet producing large earnings.
  • Share count has drifted higher over time. Diluted weighted average shares were 32.7 million in Q1 2026, up from 29.0 million in Q1 2025, which can dilute per-share upside.
  • Balance sheet includes a lot of acquired intangibles and goodwill. Goodwill and intangible assets together were roughly $54.4 million in Q1 2026, a large portion of total assets.
  • Cash dropped sharply in Q1 2026. Cash and equivalents fell from $28.6 million in Q3 2025 to $7.2 million, mainly because investing cash flow showed a $26.2 million acquisition outflow.
  • Recent acquisition spending creates execution risk. Large acquisition-related cash use could pay off if integration goes well, but it also raises the bar for future growth and synergies.
  • Operating expenses remain high relative to revenue. In Q1 2026, operating expenses were $18.6 million against $20.7 million of revenue, leaving only a thin operating margin.
  • Retained earnings remain deeply negative. Retained earnings were negative $81.1 million in Q1 2026, reflecting years of cumulative losses and highlighting the company’s history of uneven profitability.

Longer-term trend: Crexendo has clearly improved from the weaker periods in 2023 and early 2024, when operating income and net income were often slim or volatile. Revenue has grown steadily, and the company has moved into more consistent profitability in recent quarters. Still, the business has not yet reached a point where earnings or cash flow are strongly predictable, and the recent acquisition makes the next few quarters especially important to watch.

Bottom line: CXDO looks like a company with improving fundamentals and decent liquidity, but investors should keep an eye on post-acquisition cash usage, margin stability, and whether earnings can scale faster than operating expenses.

07/17/26 05:28 PM ETAI Generated. May Contain Errors.

Crexendo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Crexendo's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Crexendo's net income appears to be on an upward trend, with a most recent value of $5.07 million in 2025, falling from -$4.54 million in 2015. The previous period was $1.68 million in 2024. See Crexendo's forecast for analyst expectations on what's next for the company.

Crexendo's total operating income in 2025 was $4.69 million, based on the following breakdown:
  • Total Gross Profit: $65.33 million
  • Total Operating Expenses: $60.64 million

Over the last 10 years, Crexendo's total revenue changed from $7.82 million in 2015 to $68.17 million in 2025, a change of 771.4%.

Crexendo's total liabilities were at $13.87 million at the end of 2025, a 2.5% increase from 2024, and a 301.2% increase since 2015.

In the past 10 years, Crexendo's cash and equivalents has ranged from $619 thousand in 2016 to $31.38 million in 2025, and is currently $31.38 million as of their latest financial filing in 2025.

Over the last 10 years, Crexendo's book value per share changed from 0.17 in 2015 to 2.08 in 2025, a change of 1,146.6%.


Related Companies

Financial statements for NASDAQ:CXDO last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel